Sepio Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Sepio Capital's NVO Position: Q3 2026 in Review
Sepio Capital reduced its Novo Nordisk (NVO) stake by 1.1% in Q3 2026, selling an estimated $17.8K and leaving 35,709 shares worth $1.35M. The position accounts for 0.05% of the portfolio, ranked #138.
Sepio Capital first reported a position in NVO in Q4 2018 and has held it in 26 quarters since. The position peaked at $3.77M in Q4 2018. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Sepio Capital held 35,709 shares of Novo Nordisk worth $1.35M as of Q3 2026.
- Sepio Capital sold 386 Novo Nordisk shares in Q3 2026, an estimated $17.8K.
- Novo Nordisk made up 0.05% of Sepio Capital's portfolio in Q3 2026, its #138 holding.
- Sepio Capital first reported a position in Novo Nordisk in Q4 2018 and has held it in 26 quarters since.
- Sepio Capital's Novo Nordisk position peaked at $3.77M in Q4 2018.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Sepio Capital's 13F filing for Q3 2026, filed 22 Oct 2026.